Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples

Genes Chromosomes and Cancer

Volumn 54, Issue 11, 2015, Pages 681-691

  Kim, Jisun ^a   Kim, Sehwan ^b   Ko, Seyoon ^c   In, Yong ho ^d   Moon, Hyeong Gon ^c,e   Ahn, Soo Kyung ^e   Kim, Min Kyoon ^e   Lee, Minju ^c   Hwang, Jin Ha ^c   Ju, Young Seok ^b,c   Kim, Jong Il ^c,f   Noh, Dong Young ^c,e   Kim, Sun ^c   Park, Jung Hoon ^b   Rhee, Hwanseok ^b   Kim, Sunghoon ^d,g   Han, Wonshik ^c,e  

^a Asan Medical Center   (South Korea)

^b Macrogen Inc   (South Korea)

^c Seoul National University   (South Korea)

^d Medicinal Bioconvergence Research Center   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AKR1A1 PROTEIN; C2CD2 PROTEIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CEACAM7 PROTEIN; CYTOCHROME P450; CYTOCHROME P450 4X1; CYTOCHROME P450 4Z2P; ELONGATION FACTOR 1; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 DELTA PSEUDOGENE 3; FURRY HOMOLOG; OMA1 PROTEIN; PEROXIREDOXIN 1; PROTEIN; TACSTD2 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; MESSENGER RNA;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FUSION GENE; GENE FUSION; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS; PRIMARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; BREAST TUMOR; COMPUTER PROGRAM; FEMALE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE FUSION; HUMANS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; SOFTWARE; TRANSCRIPTOME;

EID: 84941261384     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22279     Document Type: Article

References (30)

1. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY Sougnez C, Zou L, Cortes ML, Fernandez-Lopez JC, Peng S, Ardlie KG, Auclair D, Bautista-Pina V, Duke F, Francis J, Jung J, Maffuz-Aziz A, Onofrio RC, Parkin M, Pho NH, Quintanar-Jurado V, Ramos AH, Rebollar-Vega R, Rodriguez-Cuevas S, Romero-Cordoba SL, Schumacher SE, Stransky N, Thompson KM, Uribe-Figueroa L, Baselga J, Beroukhim R, Polyak K, Sgroi DC, Richardson AL, Jimenez-Sanchez G, Lander ES Gabriel SB, Garraway LA, Golub TR, Melendez-Zajgla J, Toker A, Getz G, Hidalgo-Miranda A, Meyerson M. 2012. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486:405-409.
2. Cong J, Geng W, He B, Liu J, Charlton J, Adler PN. 2001. The furry gene of Drosophila is important for maintaining the integrity of cellular extensions during morphogenesis. Development 128:2793-2802.
3. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR. 1982. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765-767.
4. Emoto K, He Y, Ye B, Grueber WB, Adler PN, Jan LY, Jan YN. 2004. Control of dendritic branching and tiling by the Tricornered-kinase/Furry signaling pathway in Drosophila sensory neurons. Cell 119:245-256.
5. Hergovich A, Stegert MR, Schmitz D, Hemmings BA. 2006. NDR kinases regulate essential cell processes from yeast to humans. Nat Rev Mol Cell Biol 7:253-264.
6. Hirata D, Kishimoto N, Suda M, Sogabe Y, Nakagawa S, Yoshida Y, Sakai K, Mizunuma M, Miyakawa T, Ishiguro J, Toda T. 2002. Fission yeast Mor2/Cps12, a protein similar to Drosophila Furry, is essential for cell morphogenesis and its mutation induces Wee1-dependent G(2) delay. EMBO J 21:4863-4874.
7. Hofvander J, Tayebwa J, Nilsson J, Magnusson L, Brosjo O, Larsson O, von Steyern FV, Domanski HA, Mandahl N, Mertens F. 2015. RNA sequencing of sarcomas with simple karyotypes: Identification and enrichment of fusion transcripts. Lab Invest.
8. Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, Won JK, Kim YT, Kim JI, Kang JH, Seo JS. 2012. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 22:436-445.
9. Kalyana-Sundaram S, Shankar S, Deroo S, Iyer MK, Palanisamy N, Chinnaiyan AM, Kumar-Sinha C. 2012. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. Neoplasia 14:702-708.
10. Kangaspeska S, Hultsch S, Edgren H, Nicorici D, Murumagi A, Kallioniemi O. 2012. Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms. PLoS One 7:e48745.
11. Kannan K, Wang L, Wang J, Ittmann MM, Li W, Yen L. 2011. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc Natl Acad Sci USA 108:9172-9177.
12. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. 1998. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184-187.
13. McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, Sun MG, Griffith M, Heravi Moussavi A, Senz J, Melnyk N, Pacheco M, Marra MA, Hirst M, Nielsen TO, Sahinalp SC, Huntsman D, Shah SP. 2011. deFuse: An algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 7:e1001138.
14. Mertens F, Johansson B, Fioretos T, Mitelman F. 2015. The emerging complexity of gene fusions in cancer. Nat Rev Cancer 15:371-381.
15. Nagai T, Ikeda M, Chiba S, Kanno S, Mizuno K. 2013. Furry promotes acetylation of microtubules in the mitotic spindle by inhibition of SIRT2 tubulin deacetylase. J Cell Sci 126:4369-4380.
16. Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso CS, Lonigro RJ, Quist M, Siddiqui J, Mehra R, Jing X, Giordano TJ, Sabel MS, Kleer CG, Palanisamy N, Natrajan R, Lambros MB Reis-Filho JS, Kumar-Sinha C, Chinnaiyan AM. 2011. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 17:1646-1651.
17. Rowley JD. 1973. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293.
18. Scagliotti G, Stahel RA, Rosell R, Thatcher N, Soria JC. 2012. ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development. Eur J Cancer 48:961-973.
19. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H. 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561-566.
20. Stenman G, Andersson MK, Andren Y. 2010. New tricks from an old oncogene: Gene fusion and copy number alterations of MYB in human cancer. Cell Cycle 9:2986-2995.
21. Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. 2014. The landscape of kinase fusions in cancer. Nat Commun 5:4846.
22. Takeuchi K, Choi YL, Togashi Y, Soda M, Hatano S, Inamura K, Takada S, Ueno T, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H. 2009. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res 15:3143-3149.
23. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648.
24. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, Yu J, Wang L, Montie JE, Rubin MA, Pienta KJ, Roulston D, Shah RB, Varambally S, Mehra R, Chinnaiyan AM. 2007. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448:595-599.
25. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111.
26. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28:511-515.
27. Varley KE, Gertz J, Roberts BS, Davis NS, Bowling KM, Kirby MK, Nesmith AS, Oliver PG, Grizzle WE, Forero A, Buchsbaum DJ, LoBuglio AF, Myers RM. 2014. Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res Treat 146:287-297.
28. Veeraraghavan J, Tan Y, Cao XX, Kim JA, Wang X, Chamness GC, Maiti SN, Cooper LJ, Edwards DP, Contreras A, Hilsenbeck SG, Chang EC, Schiff R, Wang XS. 2014. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers. Nat Commun 5:4577.
29. Yoshihara K, Wang Q, Torres-Garcia W, Zheng S, Vegesna R, Kim H, Verhaak RG. 2014. The landscape and therapeutic relevance of cancer-associated transcript fusions. Oncogene.
30. Yun SM, Yoon K, Lee S, Kim E, Kong SH, Choe J, Kang JM, Han TS, Kim P, Choi Y, Jho S, Yoo H, Bhak J, Yang HK, Kim SJ. 2013. PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling. Oncogene.